RESECTABLE PANCREATIC CANCER
Clinical trials for RESECTABLE PANCREATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE PANCREATIC CANCER trials appear
Sign up with your email to follow new studies for RESECTABLE PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo targets pancreatic cancer before surgery
Disease control OngoingThis early-phase trial tests whether adding the targeted drug ivosidenib to standard chemotherapy can help shrink pancreatic tumors before surgery. About 16 people with resectable pancreatic cancer will take part. The main goal is to find the safest dose and see how well the comb…
Matched conditions: RESECTABLE PANCREATIC CANCER
Phase: PHASE1 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated May 17, 2026 10:39 UTC
-
Biomarker may guide chemo choices for pancreatic cancer patients
Knowledge-focused OngoingThis study looks at whether a biomarker called GATA6 can help predict how well chemotherapy works for people with pancreatic cancer that can be surgically removed. About 84 participants will receive chemotherapy before and after surgery, and researchers will measure their GATA6 l…
Matched conditions: RESECTABLE PANCREATIC CANCER
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated May 17, 2026 10:39 UTC